These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19176198)

  • 1. Optimizing therapy for acute myeloid leukemia.
    Kohrt HE; Coutre SE
    J Natl Compr Canc Netw; 2008 Nov; 6(10):1003-16. PubMed ID: 19176198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innovative strategies for adverse karyotype acute myeloid leukemia.
    Blum S; Greve G; Lübbert M
    Curr Opin Hematol; 2017 Mar; 24(2):89-98. PubMed ID: 28099271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy for older AML patients: the role of novel agents and allogeneic stem cell transplant.
    Lancet JE; Giralt S
    J Natl Compr Canc Netw; 2008 Nov; 6(10):1017-25. PubMed ID: 19176199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myeloid leukemia.
    Rubnitz JE; Gibson B; Smith FO
    Pediatr Clin North Am; 2008 Feb; 55(1):21-51, ix. PubMed ID: 18242314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consolidation therapy for adult acute myeloid leukemia: a systematic analysis according to evidence based medicine.
    Visani G; Olivieri A; Malagola M; Brunori M; Piccaluga PP; Capelli D; Pomponio G; Martinelli G; Isidori A; Sparaventi G; Leoni P
    Leuk Lymphoma; 2006 Jun; 47(6):1091-102. PubMed ID: 16840201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How I treat acute myeloid leukemia.
    Rowe JM; Tallman MS
    Blood; 2010 Oct; 116(17):3147-56. PubMed ID: 20558611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT.
    Brands-Nijenhuis AV; Labopin M; Schouten HC; Volin L; Socié G; Cornelissen JJ; Huynh A; Ljungman P; Malard F; Esteve J; Nagler A; Mohty M
    Haematologica; 2016 Feb; 101(2):248-55. PubMed ID: 26589909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute leukemia in adults].
    Eigendorff E; Hochhaus A
    Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel therapeutic strategies for AML in 2012.
    Tallman MS
    Hematology; 2012 Apr; 17 Suppl 1():S43-6. PubMed ID: 22507777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent progress in the treatment of acute leukemia].
    Kimura Y
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):895-901. PubMed ID: 12894700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapse and cytogenetic evolution in myeloid neoplasms.
    Ertz-Archambault N; Kelemen K
    Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in acute myeloid leukemia.
    Newell LF; Cook RJ
    BMJ; 2021 Oct; 375():n2026. PubMed ID: 34615640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic cell transplantation in high-risk childhood acute myelogenous leukemia.
    Meshinchi S
    Biol Blood Marrow Transplant; 2013 Jul; 19(7):1002-3. PubMed ID: 23791357
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of acute myeloid leukemia under relapsed/refractory conditions or in older adults].
    Yamauchi T
    Rinsho Ketsueki; 2016; 57(10):1934-1943. PubMed ID: 27725591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Management of Childhood Acute Myeloid Leukemia.
    Rubnitz JE
    Paediatr Drugs; 2017 Feb; 19(1):1-10. PubMed ID: 27785777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation.
    Ferguson P; Hills RK; Grech A; Betteridge S; Kjeldsen L; Dennis M; Vyas P; Goldstone AH; Milligan D; Clark RE; Russell NH; Craddock C;
    Haematologica; 2016 Nov; 101(11):1351-1358. PubMed ID: 27540133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Older patients with acute myeloid leukemia.
    Yee KW; Keating A
    Expert Rev Hematol; 2010 Dec; 3(6):755-74. PubMed ID: 21091151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic heterogeneity negatively impacts outcomes in patients with acute myeloid leukemia.
    Medeiros BC; Othus M; Fang M; Appelbaum FR; Erba HP
    Haematologica; 2015 Mar; 100(3):331-5. PubMed ID: 25527568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnormal karyotype at diagnosis: CALGB 8461 (Alliance).
    Niederwieser C; Nicolet D; Carroll AJ; Kolitz JE; Powell BL; Kohlschmidt J; Stone RM; Byrd JC; Mrózek K; Bloomfield CD
    Haematologica; 2016 Dec; 101(12):1516-1523. PubMed ID: 27470602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Frontline treatment of AML in adults].
    Miyamoto T; Kikushige Y; Yoshimoto AG
    Rinsho Ketsueki; 2017; 58(10):1884-1894. PubMed ID: 28978829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.